Skip to main content

Day: October 2, 2024

Beyond Air Partners with Healthcare Links to Expand Access to LungFit® PH System Through Group Purchasing Organizations and Integrated Delivery Networks

Revolutionary inhaled nitric oxide technology set to reach broader healthcare systems GARDEN CITY, N.Y., Oct. 02, 2024 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients, today announced entering a strategic partnership with Healthcare Links, a renowned healthcare advisory and contracting firm. This partnership is focused on expanding access to Beyond Air’s LungFit® PH system by streamlining entry into Group Purchasing Organizations (GPOs) and Integrated Delivery Networks (IDNs) across the United States. Ken Murawski, President and Founder of Healthcare Links, commented, “We are thrilled to work with Beyond Air...

Continue reading

Prairie Operating Co. Completes Acquisition of Oil-Weighted DJ Basin Assets from Nickel Road Operating

HOUSTON, Texas, Oct. 02, 2024 (GLOBE NEWSWIRE) — Prairie Operating Co. (Nasdaq: PROP) (the “Company” or “Prairie”) today announced the closing of its previously announced $84.5 million acquisition of the oil-weighted assets of Nickel Road Operating, LLC (“NRO”), a portfolio company of Vortus Investment Advisors, LLC. The NRO acquisition was funded with the proceeds from a private placement of Common Stock, an Equity Facility, and cash on hand.  Located in Weld County, Colorado, the newly acquired assets will add 5,592 net leasehold acres, 89 approved well permits, and 26 operated horizontal wells providing accretive cashflow to Prairie’s existing DJ Basin operations.   “This transaction is a major step forward in our growth strategy and an example of delivering long-term value for our shareholders,” stated Edward...

Continue reading

CLM Intersects 1.18% Li2O over 4.00 m at Vallée East Project

Presence of Lithium-Bearing Pegmatites Confirmed on the Property TORONTO, Oct. 02, 2024 (GLOBE NEWSWIRE) — Consolidated Lithium Metals Inc. (TSXV: CLM | OTCQB: JORFF | FRA: Z36) (“CLM” or the “Company“) is pleased to announce that the Company has received assay results from the spring 2024 diamond drilling program on the 100%-owned East Vallée Project. The objective of the spring drilling program was to confirm the presence and extension onto the East Vallée Project of the defined lithium-bearing pegmatites intersected by the Company during its 2023 drilling program on the adjacent Vallée Joint Venture Property. East Vallée is located in the Abitibi Greenstone Belt approximately 30 km north of Val D’Or, Quebec (see Figure 1).Figure 1: CLM Regional Projects Map [property boundaries from Company resources and historical drill hole,...

Continue reading

Titan Announces Resignations of Directors

TORONTO, Ontario, Oct. 02, 2024 (GLOBE NEWSWIRE) — Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) announces that following its annual general meeting held on September 30, 2024 (the “Meeting”) and in accordance with Titan’s Majority Voting Policy (the “Voting Policy”), Anthony Giovinazzo, Cathy Steiner, Cary Vance and Paul Cataford have tendered to the Board of Directors (the “Board”) their resignations as directors of Titan (including Paul Cataford’s resignation as Board Chairman). Pursuant to the Voting Policy, the Corporate Governance and Nominating Committee of the Corporation (“Committee”) must consider such resignations and make a recommendation to the Board as to whether to accept such resignations within ninety (90) days of the Meeting. In its deliberations, the Committee may consider, among other things, the effect...

Continue reading

Legible and CAMB.AI Join Forces to Make Literature Instantaneously Accessible in 160 Languages

VANCOUVER, British Columbia, Oct. 02, 2024 (GLOBE NEWSWIRE) — Legible Inc. (CSE: READ) (OTCQB: LEBGF) (FSE: D0T), a leading platform and innovator in digital literature, and CAMB.AI, a trendsetter in machine learning and language translation technologies, announce a strategic partnership that will leverage CAMB.AI’s versatile learning models to help translate select content on Legible’s platform into over 160 languages and dialects! As visionaries, both companies aim to empower readers worldwide to enjoy content in their preferred languages, promote global literacy, and contribute to the United Nations’ Sustainable Development Goals through enhancing education quality and preserving cultural and linguistic diversity of all kinds. This partnership is a game changer in the publishing landscape! Legible, already a trailblazer in integrating...

Continue reading

Rio2 Receives All Key Sectorial Permits for Construction of Fenix Gold Mine

VANCOUVER, British Columbia, Oct. 02, 2024 (GLOBE NEWSWIRE) — Rio2 Limited (“Rio2” or the “Company”) (TSXV: RIO; OTCQX: RIOFF; BVL: RIO) today announces that its Chilean subsidiary, Fenix Gold Limitada, has received the principal Sectorial Permits it requires to begin construction at its Fenix Gold Project (“Fenix Gold” or the “Project”) located in the Maricunga Gold Belt of the Atacama Region, Chile. These Sectorial Permits are: 1) Mining Methods; 2) Process Plant; 3) Waste Dumps & Stockpiles; and 4) Closure Plan. Andrew Cox, President & CEO of Rio2, commented, “The team at both Rio2 and Fenix Gold have done a great job in obtaining these permits, which will allow the Company to complete its debt and equity financing for the construction phase of the mine. We look forward to rapidly continuing to unlock value for all...

Continue reading

Verrica Pharmaceuticals Announces Restructuring of Commercial Organization

– Company significantly reduces cost structure with a realigned sales, marketing and operational infrastructure – Sales and marketing efforts to focus on pediatricians and expand access beyond dermatologists   WEST CHESTER, Pa., Oct. 02, 2024 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced a restructuring of its sales and operating teams to reduce costs and expand access to YCANTH® for the treatment of molluscum contagiosum. These operational changes to Verrica’s commercial organization are expected to reduce the Company’s overall cost structure by approximately fifty percent, while maintaining sufficient resources to support YCANTH® as the new standard...

Continue reading

Yorbeau Signs Agreement to Sell the Rouyn Property to Australian Investors

MONTREAL, Oct. 02, 2024 (GLOBE NEWSWIRE) — Yorbeau Resources Inc. (TSX: YRB) (the “Company” or “Yorbeau”) is pleased to announce that it has signed, on October 1, 2024, a definitive asset purchase agreement in the context of a transaction (the “Transaction”) whereby Lac Gold (Rouyn) Inc. (“Lac Gold”), a Canadian based subsidiary of Lac Gold Pty Ltd (Au) newly created for purposes of the Transaction, would, subject to certain conditions, acquire a 100% interest in Yorbeau’s Rouyn property (the “Property”). The asset purchase agreement provides that, in consideration of a 100% interest in the Property, Lac Gold must pay a purchase price of C$25,000,000 to the Company as follows:C$2,000,000 paid to the Company within 48 hours of signing; C$3,000,000 payable to the Company on the closing date of the Transaction, but no later than...

Continue reading

PharmaCorp Completes Acquisition of a Pharmacy in Atlantic Canada

SASKATOON, Saskatchewan, Oct. 02, 2024 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce that, further to its news release dated September 25, 2024, it has completed the acquisition of a 100% interest in a pharmacy business including land and buildings (the “Acquired Pharmacy”) located in Atlantic Canada (the “Acquisition”). The aggregate purchase price for the Acquired Pharmacy was $15,377,013, of which $15,177,013 was paid using cash on hand and $200,000 was paid by issuing common shares of PharmaCorp (“Common Shares”). The deemed price for the Common Shares was $0.6616 pursuant to the price adjustment mechanism included in the applicable share purchase agreement. The Acquired Pharmacy represents PharmaCorp’s third acquisition including the successful completion of its...

Continue reading

Ocugen to Present at the 2024 Cell & Gene Meeting on the Mesa

MALVERN, Pa., Oct. 02, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and vaccines, today announced that Dr. Shankar Musunuri, Chairman, Chief Executive Officer, and Co-founder of Ocugen will present at the 2024 Cell & Gene Meeting on the Mesa being held October 7-9, 2024 at the Arizona Biltmore in Phoenix, AZ. “The Cell & Gene Meeting on the Mesa convenes industry decision-makers to address all aspects of translating cutting-edge science into effective treatment options—especially where no treatment options exist,” said Dr. Musunuri. “The Alliance for Regenerative Medicine is leading the way in support of advanced therapies and this gathering reflects the organization’s impact in...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.